Back to catalogue
№ 080 27 filings · 2021-08-11 → 2026-04-23

CLS HOLDINGS PLC

CLI
Real Estate Market cap £191m Overall fit 175 /1000

Statistically cheap real estate name with credible NAV anchor, but essentially zero AI-receiver exposure, weak operating-leverage profile relative to thesis, and high balance-sheet leverage with live going-concern flag. Fails the AI pillar entirely and the downside-protection pillar; passes only on valuation discipline.

Fair value range 65p–95p Mid case · £318m
Absolute upside +66.2% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Externally appraised NAV with detailed valuation sensitivities and rent-collection at 99%
  • Concrete evidence of refinancing capacity (£373m completed in 2025) and disposals at/near book
Limits the call
  • Going-concern material uncertainty disclosed in consecutive periods
  • Controlling shareholder (55%) creates governance and exit-optionality constraints
Methodology

Discount-to-EPRA-NTA with peer cross-check

In one line · bull case

Deeply discounted European office REIT (23% of NTA) with credible refinancing track record and a £400m disposal programme that should crystallise value if execution continues.

In one line · biggest risk

Going-concern material uncertainty plus a further 10% portfolio value decline would consume available liquidity buffers and could force dilutive equity action.

Drivers
AI beneficiary 5 /100
Multi-let offices in UK/Germany/France with no data-centre, semis, or AI-tenant exposure of note; mention of one social media tenant lease is immaterial.
Operating leverage 45 /100
Material fixed-cost base and 15% vacancy give meaningful incremental margin on lettings, but high debt service absorbs most of the upside in EPRA EPS.
Earnings vs expectations 40 /100
EPRA EPS broadly meeting reduced expectations but absolute numbers declining year-on-year with dividend cut in 2025.
Growth momentum 20 /100
Net rental income -9.5%, NTA -2.6% H1 2025, dividend halved, vacancy rising — clearly negative momentum.
Moat 25 /100
Commodity multi-let office space with no structural pricing power; some local tenant relationships but no durable moat.
Earnings quality 55 /100
Headline EPRA earnings clean and cash-converting (rent collection 99%); statutory results dominated by valuation movements.
Management quality 45 /100
Long-standing CEO and competent operational delivery, but founder-trust controlling stake and weak independent-shareholder votes on Chair reduce score.
Cyclicality 75 /100
Office real estate is highly cyclical to rates and economic confidence; portfolio values down ~25% in three years.
Leverage 70 /100
LTV 49.2% with debt 76% fixed/capped; going-concern material uncertainty in interim accounts; 4.0x net debt to EPRA EBITDA-equivalent.
Value-trap signals · 6
  • Going-concern material uncertainty in 2024 and H1 2025 accounts
  • Dividend halved in 2025 (interim 2.60p to 1.30p)
  • Cumulative ~25.5% portfolio value decline since June 2022
  • Sequential decline in NTA from 350.5p (Dec 2021) to 209.5p (Jun 2025)
  • 55% controlling shareholder with weakening independent shareholder support for Chair
  • Rising group vacancy (12.7% Dec 2024 to 15.0% Sep 2025)

CLS HOLDINGS PLC (CLI) — Investment Research Note

Executive summary

CLS is a UK/Germany/France office REIT-like landlord (UK operations converted to REIT in 2022) with a £1.75bn portfolio of multi-let, predominantly non-prime offices acquired from family-controlled roots. Across the 2021–2025 period covered by the filings, the trajectory has been sharply negative: portfolio values have fallen cumulatively ~25.5% from June 2022 to June 2025, NTA has declined from 350.5p (Dec 2021) to 209.5p (Jun 2025), the dividend was halved in 2025, and a "material uncertainty" going-concern statement now sits in the H1 2025 accounts 2025-08-13 H1 2025. The single most important valuation anchor today is the discount to NTA combined with the very real refinancing/LTV stress: the equity is statistically cheap (~23% of NTA) but the cheapness reflects a fragile balance sheet rather than mispricing.

Fair value estimate

Methodology: Discount-to-NTA / sector multiple, cross-checked against peers.

  • Reported EPRA NTA at 30 June 2025: 209.5p 2025-08-13 H1 2025
  • Current share price implied by £193.1m market cap on ~398.1m shares = ~48.5p, i.e. trading at ~23% of NTA

UK office-led REITs with similar leverage profiles (49% LTV, going-concern flag) typically trade at 30–50% of NTA in the current cycle. Applying a 30–45% range to NTA, and reflecting both (i) genuine further downside risk to property values in the severe-but-plausible case (a further 10% decline modelled by management) and (ii) the option value if disposals at/above book continue (£143m of 2025 disposals at 3.5% below book; recent sales at flat-to-modest premium):

  • Fair value range: 65p – 95p per share
  • Implied market cap range: £259m – £378m (GBP)
  • vs. current £193.1m mcap
  • Upside to midpoint (80p): ~+65%

Caveat: a permanent capital impairment scenario (covenant breach, equity raise) could push fair value below current price. The fair value range therefore deliberately stops short of NAV.

Sector context

  • Sector: Real Estate / Office REITs — confirmed.
  • Quality vs. peers: below average on balance-sheet quality (LTV 49% vs. peer median ~35-40%), below average on growth (revenue declining 9.5% H1 YoY), broadly in line on portfolio quality (high-spec refurbs, good locations).
  • Listed peers: Workspace Group (WKP), Helical (HLCL), Great Portland Estates (GPE) — though CLS has a more diversified European footprint than these London-centric names. Closest European comparable is alstria (delisted) and German listed peers in tertiary office space.

Investment thesis (3 bullets)

  1. Deep discount to a stabilising NAV with refinancing risk now demonstrably manageable. Trading at ~23% of EPRA NTA (209.5p), the shares price in a far worse outcome than the data supports: £373.7m of 2025 refinancings completed, 2026+ profile evenly spread (<£200m/year), 76% fixed/capped, 1.9x interest cover 2025-12-02 trading update; 2025-08-13 H1 2025. If values stabilise (Germany already flat H2 2024, France flat H2 2024), the discount should compress.
  2. Embedded reversion + £400m sales programme provides self-help. £190m of the £400m sales programme remains; recent sales executed at or modestly above book (Les Reflets, Jarrestrasse, Spring Mews Student) demonstrate market clearing prices 2025-12-02 trading update. EPRA 'topped-up' NIY 5.4% vs. 3.75% WAC gives a 166bp positive spread to drive cashflow 2025-08-13 H1 2025.
  3. Vacancy reduction is the operational lever. 15.0% group vacancy with 2.4m sq ft of recently refurbished EPC A/B space ready to let. Post-period lettings at Artesian/Prescot Street, Pierre Valette and German government leases would add £6.0m rent and reduce vacancy by 2.2% 2025-08-13 H1 2025. Indexation (61% of rents) is providing positive contracted-rent uplifts (Germany +2.4%, France +1.5% in 9M 2025).

Key risks (3 bullets)

  1. Material uncertainty on going concern remains live. The 2024 and 2025 H1 accounts both carry an explicit going-concern material-uncertainty paragraph — refinancing of debt maturing within the going-concern window and disposal completion are outside management control 2025-08-13 H1 2025. A severe-but-plausible 10% further valuation decline would require £4m of cure payments.
  2. Controlling shareholder concentration and weak independent vote. Sten and Karin Mortstedt Family & Charity Trust holds 55.24%. Independent shareholders gave Chair Lennart Sten only 63.2% support at the 2026 AGM (50.9% at 2025 AGM) and the Director Remuneration Report received only 83.6% support — governance contention is persistent 2026-04-23 AGM result; 2025-05-16 AGM result.
  3. Structural office demand uncertainty + UK lease expiry concentration. UK vacancy at 20.8% reflects the New Printing House Square expiry and the upcoming NCA departure from Spring Gardens in September 2026 — a single tenant departure that affects one of the Group's largest properties 2025-08-13 H1 2025; 2025-12-02 trading update. Two large German tenants filed for insolvency in late 2025, adding +0.9% to group vacancy 2025-12-02 trading update.

Operating leverage

CLS's operating leverage is moderate-to-significant but constrained by the financial leverage. The cost base is largely fixed: H1 2025 EPRA cost ratio (incl. direct vacancy) was 33.3%, with administration (£8.7m) and other property expenses (£8.8m) broadly fixed against a £53.3m net rental income base 2025-08-13 H1 2025. Direct vacancy costs of £4.5m and 15.1% vacancy provide the main lever: filling that vacancy at current ERV would add c. £17.6m of contracted rent (the ERV of vacant space) at a c. 90% incremental margin after letting costs — i.e. ~£15m incremental operating profit on a base of £34.5m operating profit pre-revaluation. That is meaningful (potential +40-45% to operating profit), but most of that would be absorbed servicing debt and is offset by inflation in admin costs. A 10-20% revenue beat would add ~50-70% to operating profit, but only ~20-30% to EPRA earnings after interest because of the £19m+ semi-annual interest bill. This is not the high-leverage software-style operating story the strategy targets.

Value-trap signals

  • Going-concern material uncertainty in two consecutive annual reports 2024-08-07 H1 2024; 2025-08-13 H1 2025.
  • Sequential revenue decline: net rental income £58.9m (H1 2024) → £53.3m (H1 2025), -9.5%.
  • Dividend cut: interim halved from 2.60p to 1.30p in 2025 2025-08-13 H1 2025.
  • Repeated reductions in NTA: 350.5p → 326.6p → 253.0p → 215.0p → 209.5p across 2021–H1 2025.
  • Independent-shareholder dissent on the Chair (only 50.9% support in 2025, 63.2% in 2026) — governance friction with a 55%+ controlling shareholder.
  • Cumulative ~25.5% portfolio value decline 2022-2025 with no clear catalyst for revaluation upturn beyond rate cuts.

Earnings vs. expectations

Visibility is limited because CLS publishes guidance only through trading updates rather than formal consensus management. Where consensus is referenced: 2024 EPRA EPS came in at 9.2p vs. company-compiled consensus of 9.2p (in-line) and NTA at 215.0p vs. 216.5p (slight miss) 2025-02-24 trading update. H1 2025 EPRA EPS fell 16.7% to 4.0p, consistent with the trajectory but well below the previous 2023 H1 of 5.2p. The pattern is one of declining absolute numbers landing close to market expectations — there are no notable beats; the consistent direction is downward revisions in NTA and dividend cover, with operational metrics (rent collection 99%, leasing volumes) holding up well.

Conviction

Conviction: 3 — moderate.

  • Anchors: (i) NAV is externally appraised by Cushman & Wakefield and JLL with detailed Level 3 sensitivities disclosed; (ii) a meaningful discount to that NAV exists irrespective of methodology; (iii) refinancing progress and disposal track record provide hard evidence of solvency.
  • Limits: (i) Going-concern material uncertainty signals that a wide range of outcomes is plausible — a severe stress scenario would consume liquidity; (ii) the share price could rationally remain at a deep discount for years if values keep grinding lower; (iii) controlling shareholder governance dynamics could constrain value-maximising actions (e.g. wind-down).

Driver scoring (rationale in JSON)

Filings consulted · 26

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-04-23Result OF Agm2026-04-23_9535650_result-of-agm.md0.30
  2. 2026-03-23Publication OF 2025 Annual Report Amp Notice OF Agm2026-03-23_9487555_publication-of-2025-annual-report-amp-notice-of-agm.md0.95
  3. 2025-12-02Trading Update2025-12-02_9269030_trading-update.md0.85
  4. 2025-08-13Half Yearly Results Announcement 20252025-08-13_9048810_half-yearly-results-announcement-2025.md0.77
  5. 2025-05-16Result OF Agm2025-05-16_8883520_result-of-agm.md0.20
  6. 2025-04-14Publication OF 2024 Annual Report Amp Notice OF Agm2025-04-14_8830441_publication-of-2024-annual-report-amp-notice-of-agm.md0.62
  7. 2025-02-26Trading Update Correction2025-02-26_8754383_trading-update-correction.md0.55
  8. 2025-02-24Trading Update 24 February 20252025-02-24_8748333_trading-update-24-february-2025.md0.55
  9. 2024-11-13Trading Update 12 November 20242024-11-13_8546210_trading-update-12-november-2024.md0.55
  10. 2024-08-07Cls Holdings Half Year Report2024-08-07_8353165_cls-holdings-half-year-report.md0.58
  11. 2024-08-01Notice OF Half Year Results2024-08-01_8342617_notice-of-half-year-results.md0.58
  12. 2024-04-25Result OF Agm2024-04-25_8157761_result-of-agm.md0.14
  13. 2024-04-05Cls Investor Presentation Investor Meet Company2024-04-05_8122151_cls-investor-presentation-investor-meet-company.md0.32
  14. 2023-11-15Q3 Trading Update2023-11-15_7881686_q3-trading-update.md0.38
  15. 2023-08-09Half Year Report2023-08-09_7684490_half-year-report.md0.41
  16. 2023-04-27Result OF Agm2023-04-27_7102_result-of-agm.md0.07
  17. 2023-01-23Notice OF Full Year Results2023-01-23_7473407_notice-of-full-year-results.md0.25
  18. 2022-11-16Q3 Trading Update2022-11-16_7374217_q3-trading-update.md0.21
  19. 2022-10-13Disposal2022-10-13_7303496_disposal.md0.19
  20. 2022-09-09Result OF Agm2022-09-09_7273141_result-of-agm.md0.07
  21. 2022-08-10Half Year Results2022-08-10_7058370_half-year-results.md0.23
  22. 2022-04-28Agm Statement2022-04-28_7089514_agm-statement.md0.10
  23. 2022-03-08Acquisition2022-03-08_7062201_acquisition.md0.19
  24. 2022-02-17Acquisition2022-02-17_6851452_acquisition.md0.19
  25. 2021-11-03Trading Update2021-11-03_6657889_trading-update.md0.21
  26. 2021-08-11Half Year Report2021-08-11_6499344_half-year-report.md0.23

This research note was authored by a large language model after reading 27 regulatory filings published between 2021-08-11 and 2026-04-23. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.